Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Site Precision Study to Validate the Performance of CLAiR AI Software in Identifying Elevated Atherosclerotic Cardiovascular Disease Risk From Retinal Images.

NCT07747233 is registered in ClinicalTrials.gov with Toku Eyes Ltd as lead sponsor.

NCT NCT07747233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07747233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Site Precision Study to Validate the Performance of CLAiR AI Software in Identifying Elevated Atherosclerotic Cardiovascular Disease Risk From Retinal Images.
Lead sponsor
Toku Eyes Ltd
Phase
Not applicable
Overall status
Completed
Start date
December 5, 2025
Completion date
January 9, 2026
Enrollment
56 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk